Australia markets open in 9 hours 10 minutes

Chordate Medical Holding AB (publ) (K1Z.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0036+0.0004 (+12.50%)
As of 08:10AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 2.68M
Enterprise value 1.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.68
Price/book (mrq)1.21
Enterprise value/revenue 2.00
Enterprise value/EBITDA -0.07

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 3-89.30%
S&P500 52-week change 325.38%
52-week high 30.0320
52-week low 30.0001
50-day moving average 30.0016
200-day moving average 30.0090

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5488.09M
Implied shares outstanding 6838.15M
Float 8172.81M
% held by insiders 126.21%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,537.03%

Management effectiveness

Return on assets (ttm)-91.05%
Return on equity (ttm)-223.15%

Income statement

Revenue (ttm)1.75M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)3,099.70%
Gross profit (ttm)N/A
EBITDA -28.33M
Net income avi to common (ttm)-29.19M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.46M
Total cash per share (mrq)0.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.86
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-27.26M
Levered free cash flow (ttm)-17.71M